These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Radiofrequency ablation for hemobilia secondary to hepatocellular carcinoma.
    Author: Kim RY, Weintraub JL, Susman J, Haskal ZJ.
    Journal: J Vasc Interv Radiol; 2002 Mar; 13(3):317-20. PubMed ID: 11875092.
    Abstract:
    Hemobilia is a rare manifestation of hepatic malignancies. The current treatment of choice for hemobilia is transcatheter hepatic arterial embolization. However, there have been only two published reports that describe the use of hepatic arterial embolization for hemobilia caused by hepatic neoplasms. In addition, this procedure is occasionally unsuccessful in the treatment of hemobilia. A case in which hemobilia caused by hepatocellular carcinoma was successfully treated with percutaneous radiofrequency tumor ablation after several failed hepatic arterial embolizations is described in this report.
    [Abstract] [Full Text] [Related] [New Search]